Cargando…

Pulmonary hypertension in familial Mediterranean fever: consequence or coincidence?

Detalles Bibliográficos
Autores principales:	Sargsyan, A, Narimanyan, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596990/ http://dx.doi.org/10.1186/1546-0096-13-S1-O41

Ejemplares similares

Endothelial biomarkers in patients with familial Mediterranean fever associated vascular disease and vasculopathy
por: Sargsyan, Y, et al.
Publicado: (2015)

Canakinumab therapy in patients with Familial Mediterranean Fever
por: Ugurlu, S, et al.
Publicado: (2015)

Familial Mediterranean Fever in childhood: a single center experience
por: Barut, K, et al.
Publicado: (2015)

Investigation of the inflammatory cell migration process in familial Mediterranean fever
por: Ulum, YZ Akkaya, et al.
Publicado: (2015)

Unified modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes
por: Gul, A, et al.
Publicado: (2015)

Semaphorin 3A, a potential immune regulator in Familial Mediterranean Fever
por: Rimar, D, et al.
Publicado: (2015)

Differential expression of miR-4520a is associated with gain of function mutations in Familial Mediterranean Fever (FMF)
por: Latsoudis, H, et al.
Publicado: (2015)

Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial
por: Hashkes, PJ, et al.
Publicado: (2011)

Deletion in MEFV resulting in the loss of p.M694 residue as the cause of autosomal dominant familial Mediterranean fever in North Western European Caucasians - a case series and genetic exploration
por: Rowczenio, D, et al.
Publicado: (2015)

Comorbidities in patients with Familial Mediterranean Fever
por: Balci-Peynircioğlu, B, et al.
Publicado: (2015)

Riociguat dose titration in patients with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH)
por: Ghofrani, Hossein A, et al.
Publicado: (2009)

Neonatal onset Familial Mediterranean Fever
por: Özçakar, ZB, et al.
Publicado: (2015)

Familial Mediterranean Fever in older children
por: Özdel, Semanur, et al.
Publicado: (2014)

The role of genotype in Familial Mediterranean Fever
por: Özdel, Semanur, et al.
Publicado: (2014)

Purpura Fulminans After Varicella Infection and Pulmonary Embolism After COVID-19 Infection in Familial Mediterranean Fever: Coincidence or Not?
por: Gezgin Yıldırım, Deniz, et al.
Publicado: (2023)

Articular involvement in childhood Familial Mediterranean Fever
por: Barut, K, et al.
Publicado: (2015)

Quality of life in children with familial Mediterranean fever
por: Öztürk, Ö, et al.
Publicado: (2015)

Musculoskeletal complaints in patients with Familial Mediterranean Fever
por: Özçakar, ZB, et al.
Publicado: (2015)

Familial Mediterranean Fever associated diseases in children
por: Özçakar, ZB, et al.
Publicado: (2015)

Familial Mediterranean Fever and Human autoinflammatory diseases
por: Hovhannisyan, L
Publicado: (2015)

The association of Familial Mediterranean Fever and cryptogenic cirrhosis
por: Baskin, E, et al.
Publicado: (2008)

Challenging case of Familial Mediterranean Fever and its management
por: Al Hosani, A, et al.
Publicado: (2015)

Improvement in pulmonary hypertension discrimination using multiple MRA pant-leg parameters of pulmonary artery
por: Kilgas, Phillip, et al.
Publicado: (2014)

Increased frequency of psoriasis in the families of subjects with childhood Familial Mediterranean Fever
por: Barut, Kenan, et al.
Publicado: (2014)

L-ficolin and H-ficolin in patients with Familial Mediterranean fever
por: Mkrtchyan, G, et al.
Publicado: (2015)

Screening for inherited metabolic disorders in patients with Familial Mediterranean Fever
por: Kiykim, E, et al.
Publicado: (2015)

P01-047 – PH with right-sided heart failure in FMF
por: Sargsyan, AV, et al.
Publicado: (2013)

Familial Mediterranean Fever (FMF) before the age of one year
por: Delion, F, et al.
Publicado: (2008)

Risk factors for subclinical inflammation in children with familial mediterranean fever
por: Soylu, Alper, et al.
Publicado: (2014)

Evidence based recommendations for genetic diagnosis of Familial Mediterranean Fever
por: Giancane, Gabriella, et al.
Publicado: (2014)

Magnetic resonance imaging features of Familial Mediterranean Fever associated spondyloarthritis
por: Turan, A, et al.
Publicado: (2015)

Evaluation of right ventriculoarterial coupling in pulmonary hypertension: a magnetic resonance study
por: Sanz, Javier, et al.
Publicado: (2011)

Impaired NO-cGMP signaling in the pathogenesis of neonatal pulmonary hypertension and therapeutic implications
por: Abman, Steve H
Publicado: (2009)

Breast tumor heterogeneity: causes and consequences
por: Polyak, K, et al.
Publicado: (2009)

Chronic recurrent multifocal osteomyelitis in a patient with Familial Mediterranean Fever
por: Daia, A, et al.
Publicado: (2015)

Calprotectin (S100A8/A9) in Familial Mediterranean Fever
por: Pepper, R, et al.
Publicado: (2015)

Attacks of severe dysmenorrhea as the sole manifestation of Familial Mediterranean Fever (FMF)
por: Vitale, A, et al.
Publicado: (2008)

PReS-FINAL-2242: Familial Mediterranean Fever - first experiences in Slovakia
por: Dallos, T, et al.
Publicado: (2013)

Illegal waste sites as potential micro foci of Mediterranean Leishmaniasis
por: Ivović, V, et al.
Publicado: (2014)

Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
por: Turgay, S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i05ksgca6pdbnm2tqlf346bbnb